Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone

Journal of Investigative Dermatology

Volumn 103, Issue 4, 1994, Pages 530-533

  Hoffmann, Rolf ^a   Wenzel, Elke ^a   Huth, Andrea ^a   van der Steen, Pieter ^a   Schäufele, Monika ^a   Henninger, Hans Peter ^a,b   Happle, Rudolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

alopecia areata diphenylcyclopropenone

Indexed keywords

DIPHENCYPRONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ALLERGENS; ALOPECIA AREATA; BIOPSY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPROPANES; CYTOKINES; DERMATITIS, CONTACT; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCALP;

EID: 0028030198     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12395722     Document Type: Article

References (37)

1. Perret C. Wiesner-Menzel L. Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata Acta Dermatol Venereal (Stockh) 64 1984 26 30
2. Baadsgaard O. Lindskov R. Clemmensen O.J. In situ lymphocyte subsets in alopecia areata before and during treatment with a contact allergen Clin Exp Dermatol 12 1987 260 264
3. Bystryn J.C. Tamesis J. Immunologic aspects of hair loss J Invest Dermatol 96 1991 88 89
4. Valsecchi R. Imberti G. Martino D. Cainelli T. Alopecia areata and interleukin-2 receptor Dermatology 184 1992 126 128
5. Shapiro J. Tan J. Ho V. Abbott F. Tron V. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation J Am Acad Dermatol 29 1993 729 735
6. Nickoloff B.J. Griffiths C.E.M. Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leukocyte adhesion molecule-1 (ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata J Invest Dermatol 96 1991 91 92
7. Hamm H. Klemmer S. Kreuzer I. Steijlen P.M. Happle R. Bröcker E. HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in longstanding alopecia areata Arch Dermatol Res 280 1988 179 181
8. Khoury E.L. Price V.H. Greenspan J.S. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration J Invest Dermatol 90 1988 193 200
9. Messenger A.G. Bleehen S.S. Slater D.N. Rooney N. Expression of HLA-DR in hair follicles in alopecia areata Lancet 2 1984 287 288
10. Messenger A.G. Slater D.N. Bleehen S.S. Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology Br J Dermatol 114 1986 337 347
11. Happle R. Kalveram K.J. Büchner U. Echtemacht-Happle K. Göggelmann W. Summer K.H. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester Dermatologica 161 1980 289 297
12. Perret C.M. Happle R. Treatment of alopecia areata C.E. Orfanos R. Happle Hair and Hair Diseases 1990 Springer-Verlag Berlin, Germany 571 587
13. van der Steen P.H.M. van Baar H.J.M. Perret C.M. Happle R. Treatment of alopecia areata with diphenylcyclopropenone J Am Acad Dermatol 24 1991 253 257
14. van der Steen P.H.M. Boezeman J.B.M. Happle R. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months Dermatology 184 1992 198 201
15. Cher D.J. Mosmann T.R. Two types of murine helper T cell clones. II. Delayed-type-hypersensitivity in mediated Th1 clones J Immunol 138 1987 3688 3694
16. Griffiths C.E.M. JN W.N. Kunkel S. Nickoloff B.J. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis) Br J Dermatol 124 1991 519 526
17. Enk A.H. Katz S. Early molecular events in the induction phase of contact sensitivity Proc Natl Acad Sci USA 89 1992 1398 1402
18. Piguet P.F. Grau G.E. Hauser C. Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions J Exp Med 173 1991 673 679
19. Wei L. Müller M. Saurat J.H. Hauser C. Lymphocyte profiles in contact sensitivity induced by dinitrofluorobenzene and tolerance by dinitrothiocyanobenzene Arch Dermatol Res 284 1993 427 431
20. Chomczynski P. Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
21. Henninger H.P. Hoffmann R. Grewe M. Schulze-Specking A. Decker K. Purification and quantitative analysis of nucleic acids by anion-exchange high-performance liquid chromatography Biol Chem Hoppe-Seyler 274 1993 625 634
22. Maniatis T. Sambrock J. Fritsch E.F. Molecular Cloning, a Laboratory Manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press New York 7.39 7.41
23. Baadsgaard O. Alopecia areata: an immunologic disease? J Invest Dermatol 96 1991 89 90
24. Fong T.A.T. Mosmann T.R. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones J Immunol 143 1989 2887 2893
25. Gollnick H. Orfanos C.E. Alopecia areata: pathogenesis and clinical picture E.C. Orfanos R. Happle Hair and Hair Diseases 1990 Springer-Verlag Berlin 529 569
26. Happle R. Echternacht K. Induction of hair growth in alopecia areata with D.N.C.B Lancet 2 1977 1002 1003
27. Happle R. Klein H.M. Macher E. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata Arch Dermatol Res 278 1986 214 218
28. Bröcker E.B. Echternacht-Happle K. Hamm H. Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy J Invest Dermatol 88 1987 564 568
29. Happle R. Antigenic competition as a therapeutic concept for alopecia areata Arch Dermatol Res 267 1980 109 114
30. Gajewski T.F. Fitch F.W. Anti-proliferative effects of IFN-γ in murine regulation J Immunol 140 1988 4245 4252
31. Mosmann T.R. Cherwinski H. Bond M.W. Giedlin M.A. Coffman R.L. Two types of murine T cell clone J Immunol 136 1986 2348 2357
32. Florentine D.F. Bond M.W. Mosmann T.R. Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 1989 2081 2095
33. Mosmann T.R. Schumacher J.H. Fiorentino D.F. Leverah J. Moore K.W. Bond M.W. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10, cytokine synthesis inhibitory factor) by using a solid-phase radioimmunoadsorbent assay J Immunol 145 1990 2938 2945
34. Waal Malefyt de R. Abrams J. Bennet B. Figdor C. Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes J Exp Med 174 1991 1209 1220
35. Enk A.H. Katz S. Identification and induction of keratinocyte-derived IL-10 J Immunol 149 1992 92 95
36. Fiorentino D.F. Zlotnik A. Vicira P. Mosmann T.R. Howard M. Moore K.W. O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells J Immunol 146 1991 3444 3451
37. Enk A.H. Angeloni V.L. Udey M.C. Katz S.I. Inhibition of Langerhans cell antigen-presenting function by IL-10 J Immunol 151 1993 2390 2398